News Apr 25, 2024 Swiss biotech achieves record revenues in 2023 Swiss biotech companies generated record revenues of 7.3 billion Swiss francs in 2023, while capital investments rose 50 per cent year on year to...
Success stories Apr 23, 2024 How BeiGene drives global cancer treatment access From its European headquarters in Basel, Switzerland, BeiGene strategically collaborates with stakeholders worldwide to advance oncology research...
News Apr 23, 2024 BGG from China opens headquarters in Basel BGG is establishing new global headquarters in Basel, from which it plans to grow in Europe and the USA. The Beijing-based company is a supplier ...
News Apr 23, 2024 Swibrace advances to clinical phase with innovative 3D-printed wrist braces Swibrace, in partnership with the Inselspital in Bern, moves its customized wrist braces into clinical phase, enhancing fracture treatment throug...
News Apr 17, 2024 Addex Therapeutics launches spin-off Neurosterix in Geneva with USD 63 million investment Geneva's Addex Therapeutics has teamed up with Perceptive Advisors to launch spin-off Neurosterix, a new player in neurology-focused drug develop...
News Apr 15, 2024 First BOOM Summit deemed a success The organizers of the BOOM Summit are describing the first edition as a success. In total, 500 experts exchanged their knowledge and expertise at...
News Apr 10, 2024 Empa researchers develop cellulose-based aerogel A laboratory at the Swiss Federal Laboratories for Materials Science and Technology (Empa) has developed an ultralight, biodegradable and printab...
News Apr 09, 2024 Sitem Startup Club and CSEM forge a strategic partnership to propel medtech innovation Sitem Startup Club (SSC) has officialized a partnership with CSEM, uniting Bern's medtech ecosystem with engineering excellence for transformativ...
Success stories Apr 04, 2024 Snake venum for the Spanish pharma industry Pentapharm, a science-based company located in the Basel area, is a leading international supplier of high-quality biochemical materials for vari...
News Apr 04, 2024 Galderma completes largest IPO on a global level in Q1 Galderma has banked nearly 2.3 billion Swiss francs following its listing on the SIX Swiss Exchange. The pharma firm was therefore responsible fo...
News Apr 04, 2024 Indivi joins forces with Biogen Indivi and Biogen are cooperating on the development of digital biomarkers for Parkinson’s disease. To this end, the US biotech group is licensin...
News Apr 03, 2024 Nouscom receives additional funding for cancer vaccines Nouscom has received an investment totalling 7 million euros from the Italian venture capital firm Angelini Ventures. The Basel-based biotech com...
News Mar 28, 2024 IMT using 3D printer from Sintratec to accelerate development Information Management Technology (IMT) is using the Sintratec S2 3D printer for the production of prototype components for its development proje...
News Mar 27, 2024 TissueLabs begins biofabrication activities in Bellinzona TissueLabs has secured investment of 800,000 US dollars and has opened a new biofabrication hub in Bellinzona in the canton of Ticino. The fresh ...
News Mar 26, 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News Mar 26, 2024 Zurich researchers make cancer therapy effective again Researchers from the University of Zurich and University Hospital Zurich have discovered how mutated blood cancer cells can be made to respond to...
News Mar 20, 2024 Spineart raises CHF 20 million to push the boundaries of spinal surgery Spineart, the Geneva-based pioneer in spinal surgery innovations, has successfully secured over CHF 20 million in convertible financing.
News Mar 18, 2024 Neuria enters Vanguard Accelerator to gameify healthier lifestyles Neuria Digital Therapeutics has become the inaugural start-up of 2024 to be embraced by the Vanguard Accelerator program.